Dr. Regina Rabinovich is a global health executive with over 25 years’ experience in the research, public health, and philanthropic sectors, with focus on strategy, analytics, global health product development, and the introduction and scale-up of tools and strategies resulting in impact on endemic populations. She is also the 2012-2013 ExxonMobil Malaria Scholar in Residence at Harvard University.
Prior to joining Harvard, Dr. Rabinovich served as Director of the Infectious Diseases Unit at the Bill & Melinda Gates Foundation (from 2003-2012), overseeing the development and implementation of strategies for the prevention, treatment, and control of diseases of particular relevance to global health, including malaria, pneumonia, diarrhea, and neglected infectious diseases.
Dr. Rabinovich has also served in various positions at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), focusing on the development and evaluation of vaccines. She participated in the Children’s Vaccine Initiative, a global effort to prevent infectious diseases in children in the developing world, and served as liaison to the National Vaccine Program Office, focusing on vaccine safety and vaccine research. As chief of the Clinical and Regulatory Affairs Branch of the Division of Microbiology and Infectious Diseases, she managed the evaluation of candidate vaccines through a network of U.S. clinical research units.
In 1999, Rabinovich became director of the PATH Malaria Vaccine Initiative, a project funded by the Bill & Melinda Gates Foundation to advance efforts to develop promising malaria vaccine candidates. She joined the foundation in 2003. She serves on the boards of several organizations focused on global health and infectious diseases, including the NIAID Council and the NIH Council on Councils; PATH Vaccine Solutions; and AERAS.
Dr. Rabinovich holds a medical degree from Southern Illinois University and a Masters of Public Health degree from the University of North Carolina.